BRIEF published on 03/08/2024 at 07:05, 2 years ago Mikron Group Achieves Significant Growth in Sales and Profits in 2023 Financial Performance Mikron Holding AG Annual Results Business Segments Profit Growth
BRIEF published on 03/08/2024 at 07:05, 2 years ago Le groupe Mikron réalise une croissance significative de ses ventes et de ses bénéfices en 2023 Secteurs D'activité Résultats Annuels Mikron Holding AG Performance Financière Croissance Des Bénéfices
BRIEF published on 03/08/2024 at 07:05, 2 years ago CREALOGIX Receives Approval for Temporary Exemptions and Delisting of Shares Delisting Financial Regulations CREALOGIX Temporary Exemptions SIX Exchange Regulation
BRIEF published on 03/08/2024 at 07:05, 2 years ago CREALOGIX reçoit l'approbation d'exemptions temporaires et de radiation d'actions Règlement Financier CREALOGIX Radiation Exemptions Temporaires SIX Exchange Réglementation
BRIEF published on 03/08/2024 at 07:05, 2 years ago Kuros Biosciences to Unveil 2023 Full Year Financial Results and Corporate Developments Corporate Update Kuros Biosciences Bone Graft Technologies Annual Results Financial Results 2023
BRIEF published on 03/08/2024 at 07:05, 2 years ago Kuros Biosciences dévoilera ses résultats financiers et ses développements pour l'exercice 2023 Résultats Annuels Kuros Biosciences Résultats Financiers 2023 Mise À Jour De L'entreprise Technologies De Greffe Osseuse
BRIEF published on 03/08/2024 at 07:05, 2 years ago R&S Group Responds to VERAISON’s Plan to Return Capital to Shareholders Shareholders R&S Group Capital Return VERAISON Lock-up Agreement
BRIEF published on 03/08/2024 at 07:05, 2 years ago R&S Group répond au projet de VERAISON de restituer du capital aux actionnaires Actionnaires Rendement Du Capital VERAISON Groupe R&S Accord De Blocage
BRIEF published on 03/08/2024 at 07:05, 2 years ago Biophytis présente les avancées de RuvembriTM pour la dystrophie musculaire de Duchenne Biophytis Essais Cliniques RuvembriTM Dystrophie Musculaire De Duchenne Thérapie
BRIEF published on 03/08/2024 at 07:05, 2 years ago Biophytis Showcases RuvembriTM's Potential in Duchenne Muscular Dystrophy Treatment Biophytis Clinical Trials Orphan Drug Designation RuvembriTM Duchenne Muscular Dystrophy
Published on 03/11/2026 at 00:15, 2 hours 45 minutes ago Zeus North America Mining Corp. Announces Closing of First Tranche of Private Placement
Published on 03/10/2026 at 22:40, 4 hours 20 minutes ago Ur-Energy Updates Lost Creek Property Technical Report Summary Estimating an Extended Mine Life and Increase in Net Cash Flow
Published on 03/10/2026 at 22:30, 4 hours 30 minutes ago Ur-Energy Reports Year-End 2025 Results and Announces Conference Call and Webcast
Published on 03/10/2026 at 22:15, 4 hours 45 minutes ago Avino Reports Exceptional 2025 Results and Advances Multi-Asset Growth Strategy; Significant Improvements Across Key Financial Metrics; Treasury Reaches Record Levels
Published on 03/10/2026 at 21:30, 5 hours 30 minutes ago Mako Mining Files Technical Report for Moss Mine Mineral Resource Estimate
Published on 03/11/2026 at 00:08, 2 hours 52 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C daily buy back notice
Published on 03/10/2026 at 23:15, 3 hours 45 minutes ago Bota Launches SAION AI -- Physical AI Platform for Biomanufacturing
Published on 03/10/2026 at 21:33, 5 hours 27 minutes ago EQS-Adhoc: Gerresheimer AG: Publication of the 2025 annual and consolidated financial statements only after March 31, 2026, exclusion from the SDAX, postponement of the Annual General Meeting
Published on 03/10/2026 at 19:40, 7 hours 20 minutes ago EQS-Adhoc: Deutsche Rohstoff AG: Preliminary figures for 2025: Revenue above forecast, EBITDA at the upper end of guidance range
Published on 03/10/2026 at 18:57, 8 hours 3 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/10/2026 at 17:45, 9 hours 15 minutes ago Number of outstanding shares and voting rights as of 28 February 2026
Published on 03/10/2026 at 17:45, 9 hours 15 minutes ago Nombre de droits de vote et d'actions composant le capital social au 28 février 2026
Published on 03/10/2026 at 17:45, 9 hours 15 minutes ago OPmobility reshapes its Executive Committee to further adapt to market needs and accelerate the execution of its strategy
